At meeting held on 09 January 2018
The Board of Vista Pharmaceuticals has approved the conversion of 5 lakh warrants into 5 lakh equity shares of Rs 2 each on preferential basis at an issue price of Rs 50 per share.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
